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Abstract: In this study, we investigated stage specific expression, trafficking, solubility and topology
of endogenous PfMC-2TM in P. falciparum (3D7) infected erythrocytes. Following Brefeldin A (BFA)
treatment of parasites, PfMC-2TM traffic was evaluated using immunofluorescence with antibodies
reactive with PfMC-2TM. PfMC-2TM is sensitive to BFA treatment and permeabilization of infected
erythrocytes with streptolysin O (SLO) and saponin, showed that the N and C-termini of PfMC-2TM
are exposed to the erythrocyte cytoplasm with the central portion of the protein protected in the MC
membranes. PfMC-2TM was expressed as early as 4 h post invasion (hpi), was tightly colocalized
with REX-1 and trafficked to the erythrocyte membrane without a change in solubility. PfMC-2TM
associated with the MC and infected erythrocyte membrane and was resistant to extraction with
alkaline sodium carbonate, suggestive of protein-lipid interactions with membranes of the MC and
erythrocyte. PfMC-2TM is an additional marker of the nascent MCs.
Keywords: Plasmodium falciparum; Maurer’s clefts; PfMC-2TM; protein trafficking; clinical biomarker;
Plasmodium membrane proteins
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Plasmodium falciparum merozoites induce profound morphological changes in the host
erythrocyte cytoplasm following invasion. The erythrocyte cytoplasm is remodeled by
the parasite and results in formation of membranous structures called Maurer’s clefts [1].
Maurer’s clefts facilitate protein transport to the erythrocyte membrane, cytoskeleton and
surface [2–4]. Parasite derived proteins are transported across the parasite membrane
(PM) and parasitophorous vacuole membrane (PVM), to the erythrocyte cytoplasm and
to the surface of the infected erythrocyte through the Maurer’s clefts [5,6]. On the erythrocyte surface, knobs are formed incorporating variable surface antigens (VSAs) such
as the var gene product, P. falciparum erythrocyte membrane protein 1 (PfEMP1) [7] and
the knob-associated histidine rich protein (KAHRP). The knobs mediate cytoadherance of
the infected erythrocytes to endothelial receptors such as intracellular adhesion molecule 1
(ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and CD36 [8–11]. The var genes
along with the STEVOR, SURFIN and RIFIN genes are members of large multicopy-gene
families encoding variable proteins participating in infected red blood cell cytoadherance,
sequesteration and rosetting [12,13]. A fifth multigene family encodes the Plasmodium falciparum Maurer’s clefts two transmembrane (PfMC-2TM) proteins, consisting of 13 members
distributed on 8 chromosomes in P. falciparum. Protein sequence alignment shows 79%
sequence identity among family members. The orthologues for the PfMC-2TM genes are
present in P. reichenowi (CDC), P. billcollinsi (G01), P. blacklocki (G01) and P. praefalciparum
(G01) (PlasmodB).
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Some of the VSAs participating in knob formation associate with membranous structures in the Maurer’s clefts (MC). The ring exported protein1 (REX1) [13–15], skeletal
binding protein 1 (SBP1) [16], trophozoite exported protein 1 (TEX1) [17], Pf332 [18], membrane associated histidine rich protein 1 and 2; MAHRP1 [19] and MAHRP2 [1] play
varying roles in biogenesis, stabilizing and tethering of the clefts and also in facilitating
PfEMP1 protein transit through the clefts to the erythrocyte surface [20–23]. PfMC-2TM
possesses a canonical signal sequence that overlaps with the first transmembrane domain
and possesses PEXEL and vacuolar translocation motifs for transport through the PVM [24].
Studies show that the PEXEL motif is essential for the proteins to be exported into erythrocyte cytoplasm. However, not all proteins trafficked to the erythrocyte cytoplasm are
PEXEL dependent. Immunoelectron microscopy and colocalization studies with antibodies
against REX-1 show that PfMC-2TM is localized to the PV membrane and to the Maurer’s
clefts [24,25]. Following export into the erythrocyte cytoplasm, PfMC-2TM is shown to
have varying topological organization within the MC membrane. Amino and carboxyl
termini of PfMC-2TM have been reported oriented towards the erythrocyte cytoplasm
with the TM domains associated with the MC membrane [26]. The orientation of the two
termini was also shown to be towards the MC lumen [27] and the variable spacer between
TM domains was shown to be exposed on the erythrocyte surface [12,28]. In other studies,
PfMC-2TM was not detected on the surface of the infected erythrocyte [24,29].
Due to the conflicting data regarding the stage specific expression, traffic, topology and
membrane orientation of PfMC-2TM in the MC and erythrocyte membrane, we performed
a detailed cell biological and biochemical characterization of endogenous PfMC-2TM export in P. falciparum. Investigations of endogenous PfMC-2TM traffic from the parasite
cytoplasm to the MC have not been performed. The mechanism of PfMC-2TM export into
the erythrocyte cytoplasm is unknown. Similarly, protease accessibility studies to identify
protein topology have also not been performed. We investigated PfMC-2TM expression
following merozoite invasion and protein traffic through the parasite endomembrane system using Brefeldin A. Antisera prepared against PfMC-2TM peptides located at the N and
C termini of the protein and a monoclonal antibody specific for an epitope in the central
portion of PfMC-2TM, were used to identify the orientation of protein. The topological
association of PfMC-2TM with the MC and erythrocyte membrane was investigated using
streptolysin O (SLO) and detergent permeabilization of the infected erythrocyte and parasite membranes. Alkaline sodium carbonate fractionation and protease accessibility studies
were performed to identify the topological organization of the protein in the erythrocyte
cytoplasm, MC and infected erythrocyte membrane.
2. Results
2.1. In Silico Analysis Predicts PfMC-2TM to Possess 3 Transmembrane Domains
Protein sequence alignments of the PfMC-2TM orthologues are shown in yellow
and blue highlighted areas of Figure 1A. The sequence shows an overall 79% similarity
among the sequences from P. falciparum strains 3D7 and IT and sequences from P. reichenowi
(PlasmoDB & OrthoMCL). Twelve of the 13 PfMC-2TM multifamily proteins were predicted
to possess three transmembrane domains with the signal peptide overlapping the first
transmembrane domain at the N-terminus of the proteins from P. falciparum. In silico
analysis from PlasmoDB (http://plasmodb.org, accessed on 15 February 2021), shows that
the predicted protein PfMC-2TM expressed by PF3D7_0114100 has a length of 229 amino
acids (aa) and contains 3 transmembrane domains (Figure 1B). The predicted position of
the signal peptide (SP) spans amino acid position 1 to 12, transmembrane domain 1 (TM1),
spans amino acid position 4 to 26, transmembrane domain 2 (TM2) from position 157 to 179
and transmembrane domain 3 (TM3) from position 184 to 203 (Figure 1B). Domains were
evaluated using PlasmoDB and HMMTOP analysis. These TM domains are represented as
hydrophobic residues, with the remaining portions of the protein as polar. The predictions
of hydropathy plot and secondary structure of the sequence suggests the protein possesses
three helical structures at individual TM domain regions (PlasmoDB). Two of the three
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3 transmembrane domains (Figure 1B). The predicted position of the signal peptide (SP)
spans amino acid position 1 to 12, transmembrane domain 1 (TM1), spans amino acid
position 4 to 26, transmembrane domain 2 (TM2) from position 157 to 179 and
transmembrane domain 3 (TM3) from position 184 to 203 (Figure 1B). Domains were
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Table 1. Time points followed for collecting the synchronized 3D7 in vitro cultures.

2.2. PfMC-2TM Is Expressed by 4 h Post Merozoite Invasion

Time point
1
2

Hours post infection (hpi)

Parasite stage
Parasitemia description
In order to identify the timing
of PfMC-2TM protein expression
following merozoite
Segmenters
Shizonts (1%)
invasion
into
the
host
erythrocyte,
stage
specific
parasites
were
collected
and protein
0-4
Rings
Rings (4%)
expression identified using IFA. PfMC-2TM was detected at 4 hpi in ring stage parasites
Rings (5 %)
tightly
2A). PfMC-2TM and REX1 were localized to punctate
5-8colocalized with REX1 (FigureRings
Schizonts (0.1%)
structures in the erythrocyte cytoplasm. Protein expression progressed through the ring,
trophozoite and schizont stages with localization to cytoplasmic MC distributed within the
erythrocyte cytoplasm. At 8 and 12 hpi (early ring/mid ring stages) (Table 1), PfMC-2TM
was detected within the parasite proximal to the nucleus and also in the erythrocyte in
cytoplasmic MC. At 16 hpi and 30 hpi, (late ring to trophozoite stage of the parasite), PfMC2TM was mostly exported to the host cytoplasm of the infected RBC, with the MC localized
to the periphery of the erythrocyte membrane. In rings and trophozoites, PfMC-2TM was
mostly localized in the erythrocyte cytoplasm suggestive of the association with PVM
and MCs. In the late schizont stage, antibody reactivity was observed to be diffuse in the
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erythrocyte cytoplasm and by the segmented schizont stage at 51 hpi, the punctate MC
5 of 28
were not distinguished as the MC appeared to flatten within the erythrocyte cytoplasm.
PfMC-2TM protein expression progressed throughout the intra-erythrocytic cycle.
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Figure 2. The localization of PfMC-2TM to Maurer’s clefts immediately after parasite invasion of red blood cell. (A) Stage
Figure
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was
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and
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in
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3D7
infected
erythrocytes
was
visualized
using
SP1C1
(mAb) and co-localized with REX1 (green) specific antibodies. Infected red blood cells were percoll synchronized and
(mAb) and co-localized with REX1 (green) specific antibodies. Infected red blood cells were percoll synchronized and
collected 4, 8, 12, 16, 30, 42 and 51 h post invasion of merozoites. Expression of PfMC-2TM (red) and co-localization with
collected 4, 8, 12, 16, 30, 42 and 51 h post invasion of merozoites. Expression of PfMC-2TM (red) and co-localization with
REX1
(green).
(B)(B)
Stage
specific
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SERA1 1using
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antisera were used for endogenous expression controls. (C) Negative control normal rabbit serum and normal mouse serum
do not react with parasite proteins and uninfected red blood cells. Nuclei are stained with DAPI.
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Table 1. Time points followed for collecting the synchronized 3D7 in vitro cultures.
Time Point

Hours Post Infection (hpi)

Parasite Stage
Segmenters
Rings

1

0–4

2

5–8

Rings

3

9–12

Rings

4

13–16

Rings

5

18–30

6

31–40

7

42–51

8

51–3
(second cycle)

Late rings
Early trophozoites
Late trophozoites
Early schizonts
Schizonts
Segmenters
Segmenters
Rings

Parasitemia Description
Shizonts (1%)
Rings (4%)
Rings (5 %)
Schizonts (0.1%)
Rings (6 %)
Schizonts (<0.1%)
5% Rings
1% Early trophozoites
0.5% Late Rings
5–6% Trophozoites
5% Early schizonts
1.5% Late trophozoites
5 % Schizonts
3% rings
5% Segmented schizont

Protein expression in 4hpi rings was detected colocalized with REX-1 specific antibody.
In order to validate endogenous protein expression for the blood stage, expression levels
of SERA1 and RhopH3 proteins, used as controls to verify parasite stages and expression
of known proteins [31], were also analyzed at each time point to ensure the integrity of
stage specific protein expression (Figure 2B). SERA1 and RhopH3 proteins used as positive
controls for stage specific expression showed protein expression at each parasite stage as
reported previously [31,32].
2.3. PfMC-2TM Is Exported Using the Classical Secretory Pathway
In order to investigate the route of PfMC-2TM transport from the endoplasmic reticulum and Golgi in the parasite cytoplasm to the erythrocyte cytoplasm following protein
expression, parasites were treated with the reversible acting drug, Brefeldin A (BFA),
a fungal metabolite. BFA disrupts the function of the Golgi apparatus by blocking the
GTP-dependent interaction of ARF in a reversible manner, resulting in redistribution of
proteins into the ER [33]. RhopH3 and SERA1 sensitivity to BFA in synchronized parasites
was tested to validate known proteins trafficked in a BFA sensitive manner as positive
controls for BFA treatments (Figure 3A). Antibodies specific to the N and C termini of PfMC2TM (antiserum 703 and 704, respectively) showed similar reactivity to the monoclonal
antibody in identifying BFA sensitivity of PfMC-2TM (Figure 3B). Untreated parasites
and vehicle (ethanol) treated negative controls were also reacted with antibodies and
showed normal trafficking of proteins. In order to determine the effects of BFA treatment
on protein transport in ring and trophozoite stages and to identify compartments affected
by arrested protein traffic, BFA treatments were carried out for 16 h (rings) and 12 h
(trophozoites). When 3 h old ring stage parasites were treated with BFA for 16 h (Ring +
BFA), PfMC-2TM accumulated within the parasite in a structure surrounding the parasite
nucleus suggestive of the ER (Figure 3C). Reactivity of anti-MAHRP1was also evaluated in
BFA treated rings (Figure 3C). Anti-PfMC-2TM monoclonal antibody reactivity with 3D7
parasites was colocalized with anti-REX1 (Figure 3C). Upon release of the drug pressure,
PfMC-2TM distribution in the infected erythrocyte cytoplasm was observed localized to
punctate MCs (Figure 3C). Reactivity of BFA treated parasites with anti-ERD2 confirmed
the accumulation of proteins in the ER during drug treatment (Figure 3D). Antibodies
against the Maurer’s cleft protein Pf130 [24] showed that in contrast to PfMC-2TM, Pf130 is
insensitive to BFA treatment (Figure 3D). When 21 h old trophozoites were treated with
BFA for 12 h (Trophs + BFA), PfMC-2TM accumulated in the parasite cytoplasm. In contrast,
when the drug pressure was released after 12 h, PfMC-2TM became distributed in the
erythrocyte cytoplasm in punctate MCs proximal to the erythrocyte membrane (Figure 4B).
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After treatment of 37 h old schizonts with BFA for 9 h, PfMC-2TM was observed to be
accumulated in the erythrocyte cytoplasm. Six hours post release of the drug pressure,
PfMC-2TM was distributed in the erythrocyte cytoplasm and in MC tethered to the erythrocyte membrane (Figure 4C). Similar to the BFA treatment of ring stages, an anti-ERD2
antibody [34] was used to verify the compartments containing PFMC-2TM in BFA treated
parasites. Anti-ERD2 reactivity was detected surrounding the parasite nucleus and in
the ER. Antibody reactivity to MAHRP1 also detected protein accumulation in the parasites treated with BFA (Figures 3D and 4D). Antibodies against the N- and C-termini
of PfMC-2TM and a monoclonal antibody against PfMC-2TM had similar reactivity to
BFA treated ring, trophozoite and schizont stages demonstrating the sensitivity of PfMC2TM to BFA treatment, thus confirming trafficking of PfMC-2TM through the classical
secretory pathway (Figures 3B and 4B). Untreated and vehicle treated parasite controls
showed normal growth and viability and normal distribution of PfMC-2TM in cytosolic
membranous structures and MC by IFA (Figure 5). Negative controls using normal mouse
and rabbit serum showed no protein reactivity (Figure 5). These results show that export
Pathogens 2021, 10, x FOR PEER REVIEW
8 of 28
of PfMC-2TM to the erythrocyte cytoplasm is blocked by BFA, confirming protein export
through the classical secretory pathway.

Figure 3. Cont.
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Figure3. 3.PfMC-2TM
PfMC-2TMisisexported
exported via
via classical
classical secretory
falciparum
(3D7)
Figure
secretory pathway
pathwayduring
duringthe
thering
ringstage
stageofofPlasmodium
Plasmodium
falciparum
(3D7)
strain. Immediately after merozoite invasion, 3D7 ring stage parasites were treated with BFA for 16 h and timepoints were
strain. Immediately after merozoite invasion, 3D7 ring stage parasites were treated with BFA for 16 h and timepoints were
collected at 4, 8 and 16 h, respectively. The cells after respective timepoints were washed and recovered. (A). monoclonal
collected at 4, 8 and 16 h, respectively. The cells after respective timepoints were washed and recovered. (A). Monoclonal
antibodies (mAb) SP1C1 specific for PfMC-2TM, anti-SERA1 specific for the parasitophorous vacuole protein (SERA1),
and anti-RhopH3 (green) were used. (B) Antibodies SP1C1 specific for PfMC-2TM and antibodies specific for the C and N
termini of PfMC-2TM were used. (C) Monoclonal antibody SP1C1 (red) specific for PfMC-2TM and antibodies specific for
the MC resident proteins REX1 (green). MAHRP1 (green). (D) SP1C1 and antibody SP1A6 against the MC protein Pf130
were also incubated with anti-PfERD2. Briefly, PfMC-2TM (red), SERA1 (green), RhopH3 (green), REX1 (green) and PfERD2
(green) were visible inside the parasite in close proximity to the nucleus in Brefeldin-A treated cells. Removal of drug
pressure shows translocation of PfMC-2TM into the cytoplasm and association with the MCs in the erythrocyte cytoplasm
(Recover).
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respectively. The cells after respective timepoints were washed and recovered. (A). Monoclonal antibody antibodies (mAb)
SP1C1 specific for PfMC-2TM, anti-SERA1 specific for the parasitophorous vacuole protein (SERA1), and anti-RhopH3
(green) were used. (B) Antibodies SP1C1 specific for PfMC-2TM and antibodies specific for the C and N termini of
PfMC-2TM were used. (C) Monoclonal antibody SP1C1 (red) specific for PfMC-2TM and antibodies specific for the MC
resident proteins REX1 (green). MAHRP1 (green). (D) SP1C1 and antibody SP1A6 against the MC protein Pf130 were also
incubated with anti-PfERD2. Briefly, PfMC-2TM (red), SERA1 (green), RhopH3 (green), REX1 (green) and PfERD2 (green)
accumulated inside the parasite in close proximity to the nucleus in Brefeldin-A treated cells. Removal of drug pressure
shows translocation of PfMC-2TM into the cytoplasm and association with the MCs in the erythrocyte cytoplasm (Recover).

cific for PfMC-2TM, anti-SERA1 specific for the parasitophorous vacuole protein (SERA1), and anti-RhopH3 (green)
e used. (B) Antibodies SP1C1 specific for PfMC-2TM and antibodies specific for the C and N termini of PfMC-2TM
e used. (C) Antibodies SP1C1 (red) specific for PfMC-2TM and antibodies specific for the MC resident proteins REX1
en). MAHRP1 (green). (D) SP1C1 and antibody SP1A6 against the MC protein Pf130 were also incubated with antiPathogens
2021, 10,
431 SERA1 (green), RhopH3 (green), REX1 (green) and PfERD2 (green) accumulated inside
RD2. Briefly,
PfMC-2TM
(red),
parasite in close proximity to the nucleus in Brefeldin-A treated cells. Removal of drug pressure shows translocation
fMC-2TM into the cytoplasm and association with the MCs in the erythrocyte cytoplasm (Recover).
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parasite membrane intact (Figure 6) [35–37]. The parasite membrane remains intact so
protein in the parasite is detected in the pellet if the protein is still associated with the
parasite membrane.
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tion of PfMC-2TM was protected in association with MC membranes. Antibodies against
proteins of RhopH3 and SERA1 were used to confirm the integrity of erythrocyte, PV and
known positive control proteins of RhopH3 and SERA1 were used to confirm the integrity
parasite compartments following permeabilization. Antibodies against the high molecular
of erythrocyte, PV and parasite compartments following permeabilization. Antibodies
weight RhopH3 rhoptry protein and Serine rich antigen 1(SERA1) were used as markers
against the high molecular weight RhopH3 rhoptry protein and Serine rich antigen
for the parasite and PV, respectively. Antibody reactivity with both proteins demonstrated
1(SERA1) were used as markers for the parasite and PV, respectively. Antibody reactivity
that the integrity of the parasite and PV compartments following permeabilization and
with both proteins demonstrated that the integrity of the parasite and PV compartments
detergent treatments was intact (Figure 7C,D). We further detected REX1 in the erythrocyte
following permeabilization and detergent treatments was intact (Figures. 7C and 7D). We
cytoplasm following treatment with SLO, Sap, and trypsin alone. However, treatment with
further detected REX1 in the erythrocyte cytoplasm following treatment with SLO, Sap,
SLO + Sap + Trypsin led to decreased reactivity of REX1 in a localized section within the
and trypsin alone. However, treatment with SLO + Sap + Trypsin led to decreased reaccytoplasm (Figure 7E). Normal mouse and rabbit serum used as negative controls showed
tivity of REX1 in a localized section within the cytoplasm (Figure 7E). Normal mouse and
no reactivity with parasite proteins (Figure 7F).
rabbit serum used as negative controls showed no reactivity with parasite proteins (Figure
7F).
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2.6. PfMC-2TM Remains an Integral Membrane Protein upon Association with the
Erythrocyte Membrane
We investigated the solubility properties of PfMC2TM using Triton X-100, alkaline
sodium carbonate, urea and EDTA. Triton X-100 solubilizes peripheral and transmembrane
proteins, sodium carbonate at pH 11 extracts peripheral membrane proteins and leaves
transmembrane proteins intact in the pellet, 8M urea is a chaotropic reagent that solubilizes
and disrupts protein complexes and EDTA chelates divalent cations destabilizing membrane proteins. The different reagents were used to treat infected red blood cell membrane
ghosts obtained after hypotonic lysis of red blood cells as well as parasite pellets in the
presence of absence of proteases. PfMC2TM would be accessible to protease treatment in
domains exposed to the erythrocyte cytoplasm. Retention of PfMC2TM in the infected
membrane ghosts following alkaline carbonate extraction and treatment with urea would
indicate that the protein retained its integral membrane properties and was insoluble,
respectively. We hypothesized that PfMC- 2TM associates with the erythrocyte membrane
in addition to the MC membranes using the 3TM domains and becomes inaccessible in
the RBC membrane due to potential protein-lipid interactions. In order to verify PfMC2TM topology in association with the erythrocyte membrane, membrane ghost fractions
were prepared by hypotonic lysis using 10 mM Tris, pH 8.8 or diluted RPMI (1:5) and
fractionated with chaotropic agents, detergents, alkaline sodium carbonate and mechanical
disruption. When fractionated samples were analyzed by western blotting using PfMC2TM specific antibodies, PfMC-2TM was partially extracted by triton × 100 (Figure S1,
lane 1). PfMC-2TM was resistant to extraction by 8M urea (Figure S1, lane 2), suggesting
that the protein is insoluble. Membrane ghosts prepared from infected erythrocytes and
treated with 1 mg/mL trypsin showed that PfMC-2TM was accessible to trypsin (Figure S1,
lane 3). The protein was accessible to protease digestion with or without triton treatment
(Figure S1, lanes 3 and 4), suggesting that PfMC-2TM is exposed to the cytoplasmic side of
the infected erythrocyte. PfMC-2TM was detected in the erythrocyte membrane following
EDTA treatment alone or in combination with freeze–thaw cycles (Figure S2, lanes 5 and 6).
PfMC-2TM was not detected in the supernatants (Figure S1, lanes 7–12). Association of
PfMC-2TM with infected erythrocyte membrane was also evaluated (Figure 8). Antibodies
to the erythrocyte cytoskeletal protein α-spectrin and antibodies against the Maurer’s cleft
protein Pf130 were used for analysis. The membranes were also probed with anti-PfMC2TM (SP1C1), anti-α-spectrin and anti-Pf130 antibodies. PfMC-2TM reactivity was reduced
upon trypsin digestion. As a result, faint bands were observed in pellet and supernatant
(Figure 8, lanes 1 and 2, anti-PfMC-2TM panel). PfMC-2TM was resistant to trypsin digestion in 3D7 parasite as the 27 kDa band was detected in pellets and supernatant (Figure 8,
lane 3 and 4, anti-PfMC-2TM panel). The 27 kDa protein band was resistant to the Na2 CO3
extraction in infected red blood cell membrane ghost. The protein was found in pellet and
no band was observed in the supernatant (Figure 8 lanes 5 and 6 anti-PfMC-2TM panel).
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The function of PfMC-2TM multi-copy gene family members in pathogenesis and immune
evasion are unknown. In the current study, we performed detailed biochemical and cell
biological approaches to characterize endogenous PfMC-2TM association with the MC
and erythrocyte and parasite membranes. Following invasion of the host erythrocyte by
merozoites, the differentiated ring stage parasite becomes surrounded by the parasite
membrane, PVM and erythrocyte membrane. The three membranes are traversed by
exported and imported metabolites, nutrients and other cargo necessary for intracellular
parasite survival. In this study, we used specific antibodies targeting different sections of
the PfMC-2TM protein, to investigate the export, solubility and topology of PfMC-2TM
in the parasite and erythrocyte cytoplasm and membranes. The subcellular localization
and topological distribution of PfMC-2TM in the erythrocyte cytoplasm and erythrocyte
membrane is controversial and in need of clarification.
The first goal of this study was to identify the stage specific expression and translocation of PfMC-2TM into the erythrocyte cytoplasm. We used rabbit antisera and monoclonal
antibodies specific to PfMC-2TM in confocal microscopy to identify the stage specific
expression of PfMC-2TM in the blood stage. Timing of peak transcript expression does not
always correspond to protein expression. Available transcriptome data showed peak transcript expression 24 hpi (PlasmodB). Furthermore, [12] reported initial protein expression
at 10.5 hpi in P. falciparum 3D7 strain, with two peaks of transcription observed in clinical
isolates. We show in the current study that PfMC-2TM expression was detected as early as
4 hpi in agreement with the biogenesis of MC soon after ring stage formation. Expression at
4 hpi was detected with peptide specific antibodies and a monoclonal antibody specific for
PfMC-2TM. Tight colocalization with REX1 specific antibodies and detection of MAHRP1
and SBP1 provides further corroboration for the early expression of PfMC-2TM in the blood
stage. Protein expression may be present before 4 hpi [1]. However, in order to unambiguously detect the protein expressed early in the ring stage, parasite collection commenced at
4 hpi. Intense antibody reactivity was observed in close proximity to the parasite nucleus
at 4 hpi. By 16 hpi the protein was found to be exported to the erythrocyte cytoplasm and
the presence of punctate staining structures were observed in the erythrocyte cytoplasm.
Using antibodies against REX1, tight colocalization of REX1 and PfMC2TM were observed
at 4 hpi and through the progression of the blood stage to segmented schizonts at 51 hpi.
Our data shows that PfMC-2TM along with REX1 and SBP1 [44], is an additional marker
for the nascent MCs.
In order to understand if PfMC-2TM is synthesized and trafficked through the classical
secretory pathway for association with the MC, tightly synchronized parasites were treated
with BFA. At 3 hpi, ring stage parasites were treated with BFA for 16 h, resulting in accumulation of PfMC-2TM in the parasite. Upon removal of the drug, the protein was exported
into the erythrocyte cytoplasm and associated with the MC. At 30 hpi, trophozoites treated
with BFA showed protein accumulation in the parasite along with punctate staining of
the MC in the cytoplasm. Protein accumulation was also observed around individual
merozoites in the schizont stage of the parasite. These results confirm that the protein is
transported to the host cell cytoplasm in the ring stage of the parasite. The accumulation of
protein in close proximity to the nucleus upon treating with BFA indicates that the protein is
accumulated in the ER which indicates that the protein is exported in the classical secretory
pathway to the host cell cytoplasm. Several studies have employed long incubation times
of ring and trophozoite stage parasites in BFA, for up to 20 h to demonstrate sensitivity
of protein transport to BFA treatment [17,18,33,42,45]. In each case, protein transport was
recovered after drug removal, with protein localization to target organelles and structures.
Ref. [45] reported reversal of parasite arrest after 24 h incubation with BFA, with parasite
growth and progression into the next cycle. The use of IFA, solubility studies or metabolic
labeling with 35 [S]-methionine is used to analyze effects of BFA treatment on protein transport [33,42,45]. In the current study, IFA was used to show accumulation of protein in the
ER following BFA treatment. Anti-ERD2 reactivity colocalized with SP1C1, which verified
that proteins were accumulated in the ER as a result of BFA treatment. In eukaryotes,
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protein secretion is classified into classical and non-classical pathways [17,33]. In the classical pathway, the proteins are synthesized by ribosomes bound to the ER while protein is
translocated or inserted into the ER post translationally, followed by vesicular transport
from the ER via Golgi to the cell surface or the extracellular spaces. In contrast, molecular
mechanisms involved in the nonclassical pathway of protein traffic are independent of
ER/Golgi as reviewed in [17]. PfMC-2TM is constitutively expressed and exported to the
erythrocyte cytoplasm throughout the blood stage. PfMC-2TM possesses a signal peptide,
three transmembrane domains and has a PEXEL/HT motif which designates the protein for
transport across the PVM into the erythrocyte cytoplasm [24,30]. However, it is unknown if
plasmepsin V cleaves the PEXEL motif of PfMC-2TM for its traffic to the MCs. Antibodies
prepared to a decapeptide consisting of the first ten amino acids at the N-terminus of
PfMC-2TM recognize mature PfMC-2TM [24]. Other transmembrane proteins and members of multigene families such as RIFIN, STEVOR, PfEMP1, KAHRP, REX-2, SBP-1 and
RESA have been investigated using mutational analysis and complementation studies,
to identify sequences that facilitate protein export from the parasite through the PVM to the
erythrocyte cytoplasm [46–49]. However, PfMC-2TM has not been investigated to identify
sequences required for export and the role of the three annotated transmembrane domains
in PfMC-2TM including the role of amino acid sequences in the N and C termini of the
protein for export are unknown. Additional experiments will be performed to gain insights
into the mechanisms of processing and transport of PfMC-2TM through the PVM.
The second goal of this study was to verify the topological organization of PfMC-2TM
on the MC and infected erythrocyte membrane. Previous studies showed that PfMC-2TM
is associated with the MC and erythrocyte membrane with N and C- termini exposed to the
erythrocyte cytoplasm [26,28]. Other studies showed the N and C- termini of PfMC-2TM
in the lumen of MCs [27]. To verify if either the C-terminus or N-terminus or both of PfMC2TM protein is facing the erythrocyte cytoplasm following its association with the MC
membrane, we employed a biochemical approach based on accessibility of PfMC-2TM to
trypsin digestion after selectively permeabilizing the infected erythrocyte membrane using
streptolysin O (SLO) and saponin, digitonin and triton [24,35]. SLO selectively forms pores
on the erythrocyte plasma membrane, leaving PVM and MC membranes intact [35–37].
Saponin disrupts the RBC plasma membrane, MC membrane and PVM, but leaves the
parasite membrane intact. Digitonin and Triton on the other hand disrupt the parasite
membrane allowing parasite cytoplasmic proteins to become accessible to trypsin and
proteinase K digestion. Infected erythrocytes parasitized with late trophozoites and early
schizonts were treated with SLO and then treated with (+) or without (−) 5 mg/mL of proteinase K in a protease protection assay. In contrast to previously reported data [3}, we show
that infected membrane-associated PfMC-2TM was accessible to protease. Our results also
show that the membrane-associated PfMC-2TM is resistant to urea and sodium carbonate
extraction. Moreover, PfMC-2TM associated with the membrane was accessible to trypsin
digestion, contrary to our hypothesis. These results also differ from reports of trypsin
insensitivity obtained for membrane associated PfMC-2TM in other studies [28]. This data
suggests the varying distribution and topology of PfMC-2TM in detergent resistant subdomains of the membrane that may be accessible to protease treatment. The results do not
reflect accessibility of PfMC-2TM in MC membranes associated with infected RBC membrane ghosts following hypotonic lysis, as PfMC-2TM would still be detected in the infected
RBC membrane ghosts due to protection within the membrane following protease treatment. This data suggests the distribution of PfMC-2TM in detergent resistant sub-domains
of the membrane. It is unknown if the interactions of PfMC-2TM with the membrane are
protein-protein or protein-lipid. PfMC-2TM was both triton and urea insoluble and did
not change solubility in transit to the erythrocyte membrane. Furthermore, PfMC-2TM
was identified by antibodies in punctate MC distributed in the erythrocyte cytoplasm and
in the periphery of the infected cell proximal to the membrane in late trophozoites and
schizont stages. Variants of PfMC-2TM family members may be differentially expressed
and show different levels of reactivity with the antibodies used. This may account for
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the differences observed in both studies. How PfMC-2TM is translocated across the PVM
to become associated with the MCs and erythrocyte membrane and surface is currently
not known. Whether PfMC-2TM associates with RhopH3 in the PVM, MC and erythrocyte membrane is also unknown. RhopH1/Clag a member of the high molecular weight
rhoptry complex along with RhopH3 and RhopH2, has been shown to participate in the
formation of new permeability pathways (NPPs) in the infected erythrocyte [50,51]. One of
the transporters formed in the infected erythrocyte is the Plasmodium surface anion channel
(PSAC) shown to be important in nutrient transport. It will be important to determine if
individual members of the PfMC-2TM family associate with PSAC or other transporters in
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4.2. Stage Specific Protein Expression
Plasmodium. falciparum (strains 3D7)—infected erythrocytes were synchronized using 65% percoll to obtain 80% mature segmented schizonts as described previously [31].
Concentrated segmented schizonts were mixed with uninfected erythrocytes to obtain a
parasitemia of 3% schizonts for merozoite invasion. Five to 6% parasitemia was obtained
at reinvasion as shown in Table 1. Parasite-infected erythrocytes were collected at 4, 8, 12,

Pathogens 2021, 10, 431

22 of 27

4.2. Stage Specific Protein Expression
Plasmodium. falciparum (strains 3D7)—infected erythrocytes were synchronized
using 65% percoll to obtain 80% mature segmented schizonts as described previously [31].
Concentrated segmented schizonts were mixed with uninfected erythrocytes to obtain a
parasitemia of 3% schizonts for merozoite invasion. Five to 6% parasitemia was obtained
at reinvasion as shown in Table 1. Parasite-infected erythrocytes were collected at 4, 8, 12,
16, 30, 42 and 51 hpi. Cells were centrifuged, washed and pellets were processed for IFAs
using established lab protocols [24].
4.3. Brefeldin A Treatment
Plasmodium falciparum (3D7) segmented schizont—infected erythrocytes were synchronized using 65% percoll, washed and returned to culture until merozoite reinvasion
commenced. At 2 h post invasion (hpi), mature parasites were killed and ring-infected
erythrocytes were synchronized using 5% sorbitol. In order to investigate trafficking of
endogenous PfMC-2TM from the parasite to erythrocyte cytoplasm, synchronized parasites
were divided into eight cultures. One culture was left as an untreated control, one culture
was treated with the equivalent volume of ethanol used for solubilizing BFA and the remaining six cultures were treated with 10 µg/mL BFA at individual stages when parasites
were at ring (2 hpi), trophozoite (30 hpi) and schizont (42 hpi) stages. Duplicate cultures
were maintained at each stage. Ring stage parasites were treated with BFA and cultured for
16 h, trophozoites for 12 h and schizonts for 9 h. Following incubation with BFA, parasites
were collected, centrifuged and pellets separated from supernatant. One set of cultures
was collected after the drug treatment followed by 3 washes using RPMI-1640. Cells were
mixed with complete media and cultures resumed for another 16 h for rings, 12 h for
trophozoites and 6 h for schizonts to evaluate recovery of protein expression, translocation
and viability of the culture. Infected erythrocytes were centrifuged, supernatants were
discarded. Smears were prepared from the pellets for IFA.
4.4. Permeabilization of Schizont-Infected Erythrocytes with Streptolysin O, Saponin and Trypsin
Infected erythrocytes were treated with saponin (0.02, 0.05, 0.09, 0.15 and 0.2%) and
SLO (2, 4 and 8 units) for titration studies to determine optimum concentrations required for
experiments. Saponin concentration at 0.09% in 1X PBS was added to infected erythrocytes
and incubated for 15 min on ice in the presence of a cocktail of inhibitors [29,35]. SLO was
activated using 10 mM DTT in 1X PBS before addition to infected erythrocytes. SLO treated
cells were incubated at RT for 6 min [29], centrifuged to separate supernatant from pellets
and the pellets washed in 1 X PBS. Infected erythrocytes were fixed with 0.5% formalin on
ice for 30 min, followed by washing with 1X PBS. Late rings to early trophozoite-infected
erythrocytes divided into four 100 µL aliquots were incubated with 0.09% saponin and
4 units SLO in 1X PBS. The first aliquot was SLO treatment alone. The second aliquot
was treated with 1 mg/mL trypsin for 15 min at 37 ◦ C after SLO treatment, the third
aliquot was treated with 0.09% saponin on ice for 15 min following SLO treatment, and the
fourth aliquot was treated with a combination of saponin and mg/mL trypsin after SLO
treatment [29]. Smears were prepared for IFA as described [24].
4.5. PfMC-2TM Solubility Assays and Proteinase K Digestion of Infected Erythrocyte
Membrane Ghosts
Membrane ghosts were prepared from predominantly mid schizont-infected erythrocytes (8% parasitemia) by hypotonic lysis in 10mM Tris pH 8 or 1:5 diluted RPMI in
water [28], in the presence of a cocktail of protease inhibitor (Sigma-Aldrich, St. Louis, MO,
USA). Briefly, 1 mL of infected and uninfected erythrocytes in separate tubes were mixed
with 40 volumes of ice-cold lysis buffer, incubated for 15 min on ice and centrifuged for
30 min at 15,000 rpm at 4 ◦ C. Membrane ghosts were collected and washed three times by
centrifugation. Membrane ghosts were resuspended in 9 volumes of lysis buffer and stored
at 4 ◦ C. Four 36 µL aliquots of membrane ghosts were mixed either in 4 µL water, 4 µL 5%
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Triton X-100, 4 µL 50 mg/mL proteinase K, or 4 µL proteinase K and 5% Triton X-100 as
described [26]. Tubes were incubated on ice for 1 h, with gentle mixing. Five µL of a protease inhibitor cocktail was added, followed by 6X electrophoresis sample buffer. Samples
were boiled for 5 min for SDS-PAGE and Western blot analysis. Membrane ghosts were
also divided into eight 100 µL aliquots and incubated with 100 µL each of 1% Triton X-100
in 10 mM Tris pH 8, 1mM EDTA (1), 8 M urea in 10 mM Tris pH 8, 1 mM EDTA (2), 100 µL
200 mM sodium carbonate, pH 11.5 (3), 100 µL 200 mM sodium carbonate, pH 11.5 mixed
with ghosts after 4 cycles of freeze–thaw (4), 100 µL 1 mg/mL trypsin in 1X PBS (5), 100 µL
mg/mL trypsin; 1 % Triton X-100 in 1 X PBS (6), 100 µL 10 mM Tris pH 8, 1 mM EDTA (7)
and 100 µL of 1mM 10 mM Tris pH 8, 1mM EDTA (8). Tubes 1, 3, 4 and 7 were incubated
for 30 min on ice; tubes 2 and 8 were incubated at room temperature for 30 min and tubes 5
and 6 were incubated at 37 ◦ C for 30 min. Trypsin digestion was stopped by the addition
of Soybean trypsin inhibitor at a final concentration of 2 mg/mL along with a cocktail
of protease inhibitors. All tubes except sodium carbonate extractions were centrifuged
at 13,000 rpm for 5 min. Supernatants were separated from pellets and added to fresh
Eppendorf tubes. Sodium carbonate extractions were centrifuged in an Airfuge (Beckman
Coulter, Brea, CA, USA) at 90,000 rpm for 40 min at room temperature. Supernatants
were separated from pellets and added to fresh Eppendorf tubes. Pellets were washed
once in ice-cold distilled water by centrifugation in a microfuge, for 5 min at 13,000 rpm.
Supernatants and pellets from the eight tubes were solubilized in 6X electrophoresis sample
buffer for SDS-PAGE and Western blot analysis.
4.6. Antibodies
The following antibodies were used in immunofluorescence and confocal microscopy
studies: pooled clones of monoclonal antibodies (Mabs) SP1C1 [55], peptide-specific
rabbit antisera against three peptides from the PfMC-2TM protein encoded by gene
PFA0680c (PF3D7_0114100) [24], Maurer’s clefts-specific antibodies; anti-REX1, and antiMAHRP1 [13,56]. For the PVM, rabbit antibodies specific for SERA1 [55] and for P. falciparum RhopH3, antisera [57] were used. Monoclonal SP1C1 antibodies in spent culture
supernatant were used undiluted. Rabbit antisera against the N and C termini of PfMC2TM were diluted 1:25. Anti-ERD2 [34] (MR4, ATCC) was diluted at 1:1000, anti-SERA and
anti-RhopH3 antibodies were used at 1:50 or 1:100. Anti-REX1 and anti-MAHRP1 were
diluted 1:1000. Preimmune serum from mice and rabbits, were used as negative controls.
Secondary antibodies conjugated to Alexa 488, Alexa 568, Alexa 594, Alexa 633 and Alexa
647 (Molecular Probes, Eugene, OR, USA), diluted 1:1000 in 1× PBS, were used to detect
primary antibody reactivity.
4.7. SDS-PAGE and Western Blotting
Parasite extracts and the protein samples from the respective treatments were resolved
in 6X SDS-PAGE buffer (Amresco, Solon, OH, USA). Following electrophoretic transfer of
the separated proteins to nitrocellulose paper and blocking of unreacted sites with 2% milk,
peptide-specific antibodies and control antibodies diluted in 1× TBS (Tris buffered saline)
containing 2% nonfat dry milk (NFDM) were added to the nitrocellulose paper as primary
antibodies. Each peptide antisera from different boosts for a single peptide were pooled
and used for Western blotting. Following overnight incubation at 4 ◦ C, the nitrocellulose
papers were washed as described in [24] and incubated in anti-mouse (diluted 1:250) or
anti-rabbit (diluted 1:5000) secondary antibodies conjugated to horseradish peroxidase and
developed calorimetrically with 4-chloro-naphtol (Sigma-Aldrich, St. Louis, MO, USA).
4.8. Immunofluorescence and Confocal Microscopy
Immunofluorescence and confocal microscopy were performed as described in [24].
Microscopy was performed at the Cleveland Clinic Imaging Core, The Lerner Research
Institute, Cleveland, OH, USA. Briefly, infected erythrocyte smears were fixed in cold
methanol and acetone (1:1) for 5 min at -20 ◦ C followed by incubation with rabbit and
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mouse polyclonal antibodies either individually or together in colocalization experiments.
For colocalization assays, mouse and rabbit primary antibodies diluted as indicated above
were mixed, and secondary antibodies directed to both species, conjugated to different
colored fluorochromes, were mixed for detection of primary antibodies. Incubation with
primary antibodies was carried out for 1 h; slides were washed three times with 1× PBS
followed by incubation for 1 h with secondary mouse or rabbit antibodies conjugated to
Alexa 488, Alexa 568, Alexa 594 and Alexa 633/647 (Molecular Probes). The smears were
washed three times with 1 × PBS followed by one wash in distilled water supplemented
with 8µg/mL bis-benzimide. Vectashield containing 40 , 6-diamidino-2-phenylindole (DAPI;
Vector, Burlingame, CA, USA) or DAPI Fluoromount-G (Southern Biotech) was used to
mount the slides. Images were collected using a Leica TCS-SP5II upright laser scanning
confocal microscope (Leica Microsystems, GmbH, Wetzlar, Germany). In addition, an SP8
True Scanning Confocal (TCS) on a DMI8 inverted microscope was used to generate
differential interference contrast (DIC) images.
5. Conclusions
Maurer’s clefts are parasite derived membranous structures produced in the erythrocyte cytoplasm as a result of cytoplasmic remodeling that occur immediately following
merozoite invasion into the erythrocyte host cell. P. falciparum possesses multi-copy VSAs
encoded by var, RIFIN, STEVOR, SURFIN and PfMC-2TM genes. VSAs participate in
rosetting, knob formation and cytoadherance and are trafficked through the Maurer’s clefts
alone or chaperoned by other parasite proteins that transiently associate with the MCs
or are residents of the clefts. Permeabilization studies using SLO, saponin, digitonin and
triton X-100 together with protease protection assays show that PfMC-2TM is present in
the parasite cytoplasm, PV, MC and erythrocyte membrane. The high molecular weight
rhoptry protein RhopH3 and the PV protein SERA1 were used as markers for compartment integrity to confirm the localization of PfMC-2TM and its distribution within the
compartments. PfMC-2TM is expressed and exported using the classical secretory pathway
into the erythrocyte cytoplasm for association with the MC in a topology that orients the
N and C termini of the protein toward the erythrocyte cytoplasm as proposed in earlier
studies [26]. PfMC-2TM is also trafficked to the erythrocyte membrane as an integral
membrane protein with no change in solubility and resistant to triton and urea extraction.
PfMC-2TM although integral in its association with the erythrocyte membrane was accessible to protease digestion. Taken together, our data shows the organization of the three TMs
in the MC membrane with the sections of the protein associated with the MC membrane in
a model that shows the topology of PfMC-2TM in the erythrocyte cytoplasm (Figure 9).
The updated annotation of three TMs (PlasmodB) if accurate, may necessitate a change of
the 2TM designation for the protein family with the topology model shown in Figure 9,
if experimental data confirms the topology. Understanding the interactions of PfMC-2TM
family members with RhopH3 and the erythrocyte membrane may yield novel insights
regarding the immune and therapeutic potential of the PfMC-2TM family members.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/pathogens10040431/s1, Figure S1. Immunoblotting analysis of differential extraction of
PfMC-2TM from membrane ghosts. Lane 1, membrane ghost treated with 1% Triton X-100; lane 2,
membrane ghost treated with 8M urea; lane 3, membrane ghost treated with 1mg/ml trypsin; lane 4,
membrane ghost treated with 1% triton X-100 followed by 1mg/ml trypsin; lane 5, treated with 1M
EDTA and lane 6, membrane ghost treated with 1M EDTA with freeze/thaw cycles. The lanes 7 to 12
are the supernatants from the respective extractions. Figure S2. Membrane ghosts were subjected to
alkaline sodium carbonate (Na2 CO3 ) fractionation. Lane 1, uninfected RBC membrane ghost treated
with Na2 CO3 pellet; lane 2, uninfected RBC membrane ghost treated with Na2 CO3 supernatant;
lane 3, uninfected RBC membrane ghost treated with Na2 CO3 and 1mg/ml trypsin pellet; lane 4,
uninfected RBC membrane ghost treated with Na2 CO3 and 1mg/ml trypsin supernatant, lane 5,
infected RBC membrane ghost treated with Na2 CO3 pellet; lane 6, infected RBC membrane ghost
treated with Na2 CO3 supernatant; lane 7, infected RBC membrane ghost freeze–thaw and treated
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with Na2 CO3 pellet; lane 8, infected RBC membrane ghost freeze–thaw and treated with Na2 CO3
supernatant; lane 9, Parasites treated with Na2 CO3 pellet; lane 10, Parasites treated with Na2 CO3
supernatant; lane 11, Parasites treated with Na2 CO3 followed by trypsin digestion pellet and lane 12,
Parasites treated with Na2 CO3 followed by trypsin digestion (supernatant).
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